|
|
Volumn 88, Issue 2, 2008, Pages 132-133
|
|
OPC-67683
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 METHYL 6 NITRO 2 [4 [4 (4 TRIFLUOROMETHOXYPHENOXY)PIPERIDIN 1 YL]PHENOXYMETHYL] 2,3 DIHYDROIMIDAZO[2,1 B]OXAZOLE;
6,7 DIHYDRO 2 NITRO 6 (4 TRIFLUOROMETHOXYBENZYLOXY) 5H IMIDAZO[2,1 B][1,3]OXAZINE;
ETHAMBUTOL;
ISONIAZID;
OPC 67683;
PYRAZINAMIDE;
RIFAMPICIN;
STREPTOMYCIN;
TUBERCULOSTATIC AGENT;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
ANTIMICROBIAL ACTIVITY;
AREA UNDER THE CURVE;
BACTERIAL CELL WALL;
BACTERIAL MUTATION;
CLINICAL TRIAL;
COLONY FORMING UNIT;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SOLUBILITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TARGETING;
DRUG TISSUE LEVEL;
DRUG TOLERABILITY;
ENZYME ACTIVITY;
ENZYME INHIBITION;
HUMAN;
LIVER MICROSOME;
LONG TERM CARE;
MOLECULAR WEIGHT;
MUTAGENICITY;
MUTATION RATE;
MYCOBACTERIUM BOVIS;
MYCOBACTERIUM KANSASII;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
PLASMA CLEARANCE;
PRIORITY JOURNAL;
REVIEW;
SINGLE DRUG DOSE;
TREATMENT DURATION;
TUBERCULOSIS;
WILD TYPE;
ANIMALS;
ANTITUBERCULAR AGENTS;
HUMANS;
NITROIMIDAZOLES;
OXAZOLES;
TREATMENT OUTCOME;
TUBERCULOSIS;
|
|
EID: 43249102891
PISSN: 14729792
EISSN: None
Source Type: Journal
DOI: 10.1016/S1472-9792(08)70017-9 Document Type: Review |
|
Times cited : (14)
|
|
References (5)
|
